JUN 10, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Enspryng (Manufacturing (CMC))
U.S. Food and Drug Administration
FDA supplemental approval for manufacturing changes to an approved drug; does not report clinical efficacy or trial outcomes.
Reported
Approval date2026-06-10
Product strength120 mg/mL
BLA number761149